Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vistagen Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.1K | Sep 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTGN | Vistagen Therapeutics, Inc. | Sep 6, 2024 | 1 | $0 | 4 | Sep 10, 2024 | Director |
VTGN | Vistagen Therapeutics, Inc. | Mar 4, 2024 | 1 | $0 | 4 | Mar 6, 2024 | Director |
VTGN | VistaGen Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | CHIEF COMMERCIAL OFFICER, Director |